ReviewJournal of immunology research2014

Potential benefits of therapeutic use of β2-adrenergic receptor agonists in neuroprotection and Parkinsonμs disease.

Lynda Peterson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.